Tasigna

Blue purple pink 3d rendering of brain
Research

How Novartis' Tasigna restores dopamine in Parkinson's disease

Parkinson's patients in a trial of Novartis' Tasigna showed a boost in dopamine that may have halted the decline of motor and non-motor functions.
Arlene Weintraub Dec 16, 2019 11:00am
3D brain against purple background

Repurposing Novartis’ cancer drug Tasigna in Parkinson’s

Mar 13, 2019 11:23am
Lab work

Novartis cancer drug to be tested for Parkinson’s disease

Jul 13, 2016 6:35am